H30.013
Focal chorioretinal inflammation, juxtapapillary, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Focal chorioretinal inflammation, juxtapapillary, bilateral, is a condition that affects the layers of the eye, specifically the choroid and retina. It involves localized inflammation near the optic nerve head (juxtapapillary region) and affects both eyes. This condition can impact vision and requires proper diagnosis and management from eye care professionals.
Causes & Symptoms
Clinical Causes: Infections such as toxoplasmosis, tuberculosis, or syphilis Autoimmune diseases like sarcoidosis or Vogt-Koyanagi-Harada syndrome Idiopathic (unknown causes), where no specific reason can be identified Underlying systemic inflammatory or infectious conditions Secondary to other eye diseases or trauma
Key Symptoms: Blurred or decreased visual acuity Floaters or spots in vision Discomfort or mild pain around the eye Redness or swelling around the affected eye Sensitivity to light (photophobia) Visual field disturbances or loss in the affected area
Diagnostic & Treatment
Diagnosis Path: Visual acuity testing to assess sight clarity Fundoscopy (ophthalmoscopy) allows direct visualization of the retina and choroid Optical coherence tomography (OCT) to visualize retinal layers Fluorescein angiography to evaluate blood flow and areas of leakage or inflammation Blood tests to identify infectious or autoimmune causes Imaging studies like MRI if systemic disease is suspected
Treatment Protocols: Corticosteroids, administered topically or systemically, to control inflammation Immunosuppressive medications if autoimmune processes are involved Antimicrobial therapy if infection is identified Close monitoring through follow-up eye exams Management of underlying systemic conditions
Clinical Advice & FAQs
Billing Guidance
Is H30.013 a billable ICD-10 code?
Yes, H30.013 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H30.013?
Clinical documentation must specify the nature of Focal chorioretinal inflammation, juxtapapillary, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference